WuXi Biologics (Cayman) Inc.
2269
Rang în acțiuni
#987
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Preț acțiune
$5.77
Capitalizare de piață
$23.74B
Schimbare (1 zi)
-8.38%
Schimbare (1 an)
25.13%
Țară
CN
Tranzacționează WuXi Biologics (Cayman) Inc. (2269)
Categorie
Healthcare
Venituri pentru WuXi Biologics (Cayman) Inc. (2269)
Venituri în Oct 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale WuXi Biologics (Cayman) Inc., venitul actual al companiei (TTM) este 0. În anul 2026, compania a avut un venit de 0 egal cu venitul din anul 2026, care a fost de 0. Venitul reprezintă suma totală generată de o companie din vânzarea de bunuri sau servicii. Spre deosebire de profit, cheltuielile nu sunt scăzute.
Istoricul veniturilor pentru WuXi Biologics (Cayman) Inc. din 2014 până în 2026
Venituri la sfârșitul fiecărui an
| An | Venituri | Schimbă |
|---|---|---|
| 2025 | $3.11B | 21.73% |
| 2024 | $2.56B | 6.32% |
| 2023 | $2.41B | 8.72% |
| 2022 | $2.21B | 36.72% |
| 2021 | $1.62B | 88.45% |
| 2020 | $859.12M | 50.17% |
| 2019 | $572.10M | 55.27% |
| 2018 | $368.45M | 48.08% |
| 2017 | $248.81M | 74.67% |
| 2016 | $142.45M | 66.06% |
| 2015 | $85.78M | 60.11% |
| 2014 | $53.58M | 0.00% |
Venituri pentru companii similare sau concurente
| Companie | Venituri | Diferență de venituri | Țara |
|---|---|---|---|
| $12.62B | - |
US
|
|
| $2.23B | - |
US
|
|
| $15.74B | - |
AU
|
|
| $6.02B | - |
NL
|
|
| - | - |
CH
|
